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Abstract 
 
With the growing importance of positron emission tomography (PET) for in vivo 
imaging in diagnostic medicine there is great interest of developing new labelling 
methods for the positron emitter selenium-73. As attractive application an examina-
tion of a no-carrier-added (n.c.a.) preparation of the analogous tracer Sulindac Sele-
nid and of the selenium containing compound Ebselen was examinated with 73,75Se. 
First of all a labelling strategy for Sulindac Selenid based on a protected precur-
sor was developed. This precursor should further be transformed into the corre-
sponding standard compound for chomatographic identification of the n.c.a. product. 
This, however, was not possible. An alternative synthesis method also did not result 
in a product. Thus, a radioactive labelling in case of Sulindac Selenid was not indi-
cated in spite of a successful synthesis of a precursor. 
The preparation of Ebselen was performed as earlier described by a sequential 
one-pot synthesis with a yield of 46 %. An adaption of the reaction parameters to a 
radiosynthesis with 75Se failed on the n.c.a. state and also after adding carrier to the 
reaction mixture. The desired product could, however, be prepared in a copper cata-
lysed one-pot radiosynthesis for the first time under carrier-added conditions. Here, 
optimized conditions resulted in radiochemical yields of 60 ± 18 %. 
A no-carrier-added product could finally be achieved using sulphur as non-
isotopic carrier in the reaction mixture. After optimisation of reaction parameters 
n.c.a. [75Se]Ebselen could be synthesized with radiochemical yields of 55 ± 7 % with-
in 4 h. Furthermore the desired product could be separated by RHPL-
chromatography from its co-produced sulfur-analogue. 
After transferring the conditions to radiosyntheses with the positron emitter 73Se, 
n.c.a. [73Se]Ebselen could be achieved with a radiochemical yield of 22 ± 1 % and 
can now be used as a potential radiotracer in preclinical evaluation studies with re-
spect to tracer application with PET. First in vitro distributions studies with slices of 
rat brain were already performed by autoradiography. 
 
 
